Clinical and laboratory evaluation of patients with primary antiphospholipid syndrome according to the frequency of antinuclear antibodies (ANA Hep-2)

Revista Brasileira de Reumatologia

Volumn 50, Issue 3, 2010, Pages 267-272

  de Carvalho, Jozélio Freire ^a   Caleiro, Maria Teresa Correia ^a   Vendramini, Margarete ^b   Bonfá, Eloísa ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Rheumatology Department of FMUSP

Author keywords

Anticardiolipin; Antiphospholipid syndrome; Autoantibodies; Cellular antibodies in Hep 2 cells; Primary antiphospholipid syndrome

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; CHLOROQUINE; CORTICOSTEROID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY; WARFARIN;

ACUTE HEART INFARCTION; ADULT; ANGINA PECTORIS; ANTIBODY DETECTION; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; BONE NECROSIS; CEREBROVASCULAR ACCIDENT; CLINICAL EVALUATION; COMORBIDITY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; HEP 2 CELL; HUMAN; HYPERTENSION; ISCHEMIA; LABORATORY TEST; LIFESTYLE MODIFICATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; SNEDDON SYNDROME; THROMBOCYTOPENIA; ADOLESCENT; BLOOD; MIDDLE AGED;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 77954697552     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hughes GR. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J 1983; 287:1088-9.
2. Gardner GC, Kadel NJ. Ordering and interpreting rheumatologic laboratory tests. J Am Acad Orthop Surg 2003; 11:60-7.
3. Slater CA, Davis RB, Shmerling RH. Antinuclear antibody testing. A study of clinical utility. Arch Intern Med 1996; 156:1421-5.
4. Paprotnik S, Bozic B, Kveder T, Rozman B. Fluctuation of anti-Ro/ SS-A anitbody levels in patients with systemic lupus erythematosus and Sjögren's syndrome: A prospective study. Clin Exp Rheumatol 1999; 17:63-8.
5. Charles PJ, Van Venrooij WJ, Maini RN. The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases: 1989-1992. Clin Exp Rheumatol 1992; 10:507-11.
6. Kurien BT, Scofield RH. Autoantibody Determination in the Diagnosis of Systemic Lupus Erythematosus. Scandinavian J Immunology 2006; 64:227-35.
7. Kurien BT, Scofield RH. Autoantibody Determination in the Diagnosis of Systemic Lupus Erythematosus. Scandinavian Journal of Immunology. 2006; 64:227-35.
8. Riboldi P, Gerosa M, Moroni G, Radice A, Allegri F, Sinico A et al. Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus? Autoimmunity 2005; 38:39-45.
9. Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, Brot N et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987; 317:265-71.
10. Migliorini P, Baldini C, Rocchi V, Bombardieri S. Anti-Sm and anti- RNP antibodies. Autoimmunity 2005; 38:47-54.
11. Meyer O, Piette JC, Bourgeois P, Fallas P, Bletry O, Jungers P et al. Antiphospholipid antibodies: a disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE. J Rheumatology 1987; 14:502-6.
12. Andreoli L, Pregnolato F, Burlingame RW, Allegri F, Rizzini S, Fanelli V et al. Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity? J Autoimmun 2008; 30:51-7.
13. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42:1309-11.
14. Willkens RF, Whitaker RR, Anderson RV, Berven D. Significance of antinuclear factors in older persons. Ann Rheum Dis 1967; 26:306-10.
15. Dellavance A, Gabriel Jr A, Nucitelli B, Taliberti BH, Von Mühlen CA. Pesquisa de autoanticorpos em células Hep-2. Goiânia: Editora UCG, 2008.
16. Dellavance A, Gabriel-Jr A, Cintra AFU, Ximenes AC, Nuccitelli B, Taliberti BH et al. II Consenso Brasileiro de Fator Antinuclear em Células Hep-2. Definições para a padronização da pesquisa de autoanticorpos contra constituintes do núcleo (FAN Hep-2), nucléolo, citoplasma e aparelho mitótico e sua associações clínicas. Rev Bras Reumatol 2003; 43:129-40.
17. Aarden LA, de Groot ER, Feltkamp TE. Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann N Y Acad Sci 1975; 254:505-15.
18. Kurata N, Tan EM. Identification of antibody to nuclear acidic antigens by counterimmunoelectrophoresis. Arthritis Rheum 1976; 19:574-80.
19. Elkon KB, Culhane L. Partial immunochemical characterization of the Ro and La proteins using antibodies from patients with the sicca syndrome and lupus erythematosus. J Immunol 1984; 132:2350-6.
20. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46:1-6.
21. Neri R, Tavoni A, Cristofani R, Levanti C, Sodini G, d'Ascanio A et al. Antinuclear antibody profile in Italian patients with connective tissue diseases. Lupus 1992; 1:221-7.
22. Harmon CE. Antinuclear antibodies in autoimmune disease. Significance and pathogenicity. Med Clin North Am 1985; 69:547-63.
23. Ho KT, Reveille JD. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 2003; 5:80-93.
24. Spencer-Green G, Alter D, Welch HG. Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies. Am J Med 1997; 103:242-8.
25. Bridges AJ. Autoantibodies in patients with silicone implants. Semin Arthritis Rheum 1994; 24:54-60.
26. Blanco Y, Ramos-Casals M, García-Carrasco M, Cervera R, Font J, Ingelmo M. Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: a report of 3 new cases and a review of the literature. Rev Clin Esp 1999; 199:586-8.
27. Carbone J, Orera M, Rodríguez-Mahou M, Rodríguez-Pérez C, Sánchez-Ramón S, Seoane E et al. Immunological abnormalities in primary APS evolving into SLE: 6 years follow-up in women with repeated pregnancy loss. Lupus 1999; 8:274-8.
28. Shoenfeld Y, Twig G, Katz U, Sherer Y. Autoantibody explosion in antiphospholipid syndrome. J Autoimmun 2008; 30:74-83.
29. To CH, Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum 2005; 52:4003-10.
30. Mok CC, Tang SS, To CH, Petri M. Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups. Arthritis Rheum 2005; 52:2774-82.
31. Somers E, Magder LS, Petri M. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol 2002; 29:2531-6.
32. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349:1526-33.